AGP Picks
View all

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on November 12, 2026

Peer-Reviewed Research Conducted by Oral Biolife on Success of Regenerative Dental Hydrogel Published in Gels Journal
SCAN’s Independence at Home to Deliver Thanksgiving Meals and Care Packages to Older Adults and People Experiencing Homelessness
Top 8 Medical Clinical Thermometer Companies in 2026: NINGBO HI-LIFE Medical Technology
Bespoke Fit Launches 14-Day Free Trial of World's First Unlimited Live 1-on-1 Personal Training App
ANY.RUN Helps European Organizations Strengthen NIS2 Readiness with Independent Threat Intelligence
EMMA International Launches Emerging Professionals Program to Support the Next Generation of Life Sciences Leaders
From 51 Doctors to a $50,000 HHS Award: UCLA Senior Olivia Goodreau Uses AI to Fight Lyme Disease
NPO: World Kindness Day Not Enough, Adopt Planned Acts of Kindness and HEART Initiatives for Lasting Quality of Life
Veridas Successfully Integrates its Identity Verification Solutions with Epic to Secure Digital Healthcare Access
Java security flaws surge sevenfold in 2026, but attacks against them don't follow
Our God of Second Chances Traces Love Rekindled Across Decades and Faith Tested by Illness
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
Certified Nurse Midwife Kim Windels: 40 Years in Home Birth and Women's Health in Northern Colorado and Southern Wyoming
Windward Bio Announces Pricing of Initial Public Offering
Vivan Therapeutics set to Begin TuMatch™ Clinical Registration Study at Burjeel Cancer Institute, Abu Dhabi
Gallery Collection Reveals 2026 Business Holiday Card Trends: Tradition Meets Personalization
VitalHub Reports Third Quarter 2026 Results
Tony Williamson Reaches $14.3M in Sales Around Cairns Hospital
INDIGO Biosciences Launches Calcitonin Reporter Assay to Support Drug Discovery and Peptide Therapeutic Development
POTS Phase 2 Trial Shows Baloncibart, a First-in-Class NPR1 Blocking Antibody, Reduced Orthostatic Heart Rate and Improved Orthostatic Symptoms

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.